Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1
- PMID: 11793011
- DOI: 10.1038/nature711
Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1
Abstract
Neurofibromatosis type I (NF1) is one of the most common single-gene disorders that causes learning deficits in humans. Mice carrying a heterozygous null mutation of the Nfl gene (Nfl(+/-) show important features of the learning deficits associated with NF1 (ref. 2). Although neurofibromin has several known properties and functions, including Ras GTPase-activating protein activity, adenylyl cyclase modulation and microtubule binding, it is unclear which of these are essential for learning in mice and humans. Here we show that the learning deficits of Nf1(+/-) mice can be rescued by genetic and pharmacological manipulations that decrease Ras function. We also show that the Nf1(+/-) mice have increased GABA (gamma-amino butyric acid)-mediated inhibition and specific deficits in long-term potentiation, both of which can be reversed by decreasing Ras function. Our results indicate that the learning deficits associated with NF1 may be caused by excessive Ras activity, which leads to impairments in long-term potentiation caused by increased GABA-mediated inhibition. Our findings have implications for the development of treatments for learning deficits associated with NF1.
Similar articles
-
The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1.Curr Biol. 2005 Nov 8;15(21):1961-7. doi: 10.1016/j.cub.2005.09.043. Curr Biol. 2005. PMID: 16271875
-
A mouse model for the learning and memory deficits associated with neurofibromatosis type I.Nat Genet. 1997 Mar;15(3):281-4. doi: 10.1038/ng0397-281. Nat Genet. 1997. PMID: 9054942
-
NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response.Circulation. 2007 Nov 6;116(19):2148-56. doi: 10.1161/CIRCULATIONAHA.107.707752. Epub 2007 Oct 22. Circulation. 2007. PMID: 17967772
-
Molecular and cellular mechanisms underlying the cognitive deficits associated with neurofibromatosis 1.J Child Neurol. 2002 Aug;17(8):622-6; discussion 627-9, 646-51. doi: 10.1177/088307380201700813. J Child Neurol. 2002. PMID: 12403561 Review.
-
Recent developments in neurofibromatosis type 1.Curr Opin Neurol. 2007 Apr;20(2):135-41. doi: 10.1097/WCO.0b013e3280895da8. Curr Opin Neurol. 2007. PMID: 17351482 Review.
Cited by
-
Valosin-containing protein and neurofibromin interact to regulate dendritic spine density.J Clin Invest. 2011 Dec;121(12):4820-37. doi: 10.1172/JCI45677. Epub 2011 Nov 21. J Clin Invest. 2011. PMID: 22105171 Free PMC article.
-
GABA deficiency in NF1: A multimodal [11C]-flumazenil and spectroscopy study.Neurology. 2016 Aug 30;87(9):897-904. doi: 10.1212/WNL.0000000000003044. Epub 2016 Jul 29. Neurology. 2016. PMID: 27473134 Free PMC article.
-
Loss of Cav1.2 channels impairs hippocampal theta burst stimulation-induced long-term potentiation.Channels (Austin). 2020 Dec;14(1):287-293. doi: 10.1080/19336950.2020.1807851. Channels (Austin). 2020. PMID: 32799605 Free PMC article.
-
Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses.Front Mol Neurosci. 2013 Aug 5;6:19. doi: 10.3389/fnmol.2013.00019. eCollection 2013. Front Mol Neurosci. 2013. PMID: 23935565 Free PMC article.
-
Reduced higher dimensional temporal dynamism in neurofibromatosis type 1.Neuroimage Clin. 2019;22:101692. doi: 10.1016/j.nicl.2019.101692. Epub 2019 Jan 29. Neuroimage Clin. 2019. PMID: 30710873 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous